Mechanistically, we found that LINC01391 functions through a ceRNA-involved mechanism via competing with miR-12116, thus triggering CMTM2 expression and restraining the cell viability, invasion and aerobic glycolysis of GC cells. This evidence concerns the gene LINC01391 and gastric cancer.